| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | TUBA3D POTEF TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B POTEE TUBA1A TLN2 POTEI | 2.04e-10 | 130 | 146 | 12 | GO:0005200 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB25 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C GFM2 EEF1A1P5 SH3BP4 TUBA1B RAB28 TUBA1A RHOF AGAP1 AGAP3 | 8.19e-07 | 439 | 146 | 15 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB25 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C GFM2 EEF1A1P5 SH3BP4 TUBA1B RAB28 TUBA1A RHOF AGAP1 AGAP3 | 8.19e-07 | 439 | 146 | 15 | GO:0019001 |
| GeneOntologyMolecularFunction | GTP binding | RAB25 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C GFM2 EEF1A1P5 TUBA1B RAB28 TUBA1A RHOF AGAP1 AGAP3 | 1.34e-06 | 397 | 146 | 14 | GO:0005525 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 6.05e-05 | 11 | 146 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.50e-04 | 37 | 146 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.32e-04 | 118 | 146 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural molecule activity | TUBA3D POTEF TUBA1C LAMA2 TUBA3E OTOL1 TUBA4A TUBA3C BICD1 TUBA1B POTEE TUBA1A MRPS15 TLN2 ELN POTEI RPL9 | 2.83e-04 | 891 | 146 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.88e-04 | 18 | 146 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.41e-04 | 19 | 146 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS2 RAB25 CHD8 GFM2 EEF1A1P5 TUBA1B RAB28 ATP6V1H MLH3 KIF15 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 5.65e-04 | 775 | 146 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYH2 PMS2 EP400 CHD8 ATP6V1H MLH3 KIF15 ATP6V1D SMARCA2 MYH15 DNAH5 DNAH9 | 5.85e-04 | 614 | 146 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | chromatin binding | SATB2 EP400 CHD8 SKI HDAC7 DNAJC2 SETDB1 TDRD3 ARID1B MLH3 KAT8 SMARCA2 ASXL2 CRTC2 | 1.06e-03 | 739 | 146 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | dynein complex binding | 1.10e-03 | 28 | 146 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.10e-03 | 28 | 146 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS2 RAB25 CHD8 GFM2 EEF1A1P5 TUBA1B RAB28 ATP6V1H MLH3 KIF15 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 1.26e-03 | 839 | 146 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS2 RAB25 CHD8 GFM2 EEF1A1P5 TUBA1B RAB28 ATP6V1H MLH3 KIF15 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 1.27e-03 | 840 | 146 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS2 RAB25 CHD8 GFM2 EEF1A1P5 TUBA1B RAB28 ATP6V1H MLH3 KIF15 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 1.27e-03 | 840 | 146 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.63e-03 | 32 | 146 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.73e-03 | 70 | 146 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.43e-03 | 127 | 146 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.48e-03 | 37 | 146 | 3 | GO:0140658 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC42BPA CFAP73 TPPP2 TUBA3D TUBA1C CNTRL STMN2 TUBA3E TUBA4A TUBA3C BICD1 TUBA1B MET KIF15 TUBA1A DNAH5 CCDC65 | 1.53e-05 | 720 | 147 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 CDC42BPA CFAP73 TPPP2 TUBA3D IFT81 TUBA1C CNTRL STMN2 TUBA3E TUBA4A TUBA3C BICD1 CDR2L TUBA1B MET KIF15 TUBA1A DNAH5 CCDC65 DNAH9 | 2.01e-05 | 1058 | 147 | 21 | GO:0007017 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 3.17e-06 | 32 | 151 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 3.17e-06 | 32 | 151 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.78e-05 | 45 | 151 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.94e-05 | 25 | 151 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule | RIBC2 TPPP2 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B KIF15 TUBA1A DNAH5 DNAH9 PTPN20 | 3.35e-05 | 533 | 151 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 CDKL2 RBBP6 IFT81 CNTRL KIAA0586 SKI C2CD5 BICD1 RAB28 RESF1 KIF15 KIAA1217 ATP6V1D MAD1L1 NLRC5 CCDC65 PTPN20 LRIF1 | 3.63e-05 | 919 | 151 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 RIBC2 TPPP2 PYROXD1 TUBA3D POTEF TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B POTEE KIF15 TUBA1A MYH15 ELN POTEI DNAH5 DNAH9 PTPN20 | 1.17e-04 | 1179 | 151 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 RIBC2 TPPP2 PYROXD1 TUBA3D POTEF TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B POTEE KIF15 TUBA1A MYH15 ELN POTEI DNAH5 DNAH9 PTPN20 | 1.29e-04 | 1187 | 151 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | axoneme | 1.34e-04 | 207 | 151 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.38e-04 | 208 | 151 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | centrosome | CCDC14 CDKL2 RBBP6 IFT81 CNTRL KIAA0586 SKI C2CD5 BICD1 KIF15 KIAA1217 ATP6V1D MAD1L1 NLRC5 PTPN20 LRIF1 | 1.47e-04 | 770 | 151 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | RIBC2 TPPP2 TUBA3D POTEF TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B POTEE KIF15 TUBA1A POTEI DNAH5 DNAH9 PTPN20 | 2.76e-04 | 899 | 151 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.03e-04 | 94 | 151 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | dynein complex | 6.25e-04 | 54 | 151 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 9.53e-04 | 104 | 151 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.18e-03 | 109 | 151 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.19e-03 | 317 | 151 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | cilium | DNHD1 RIBC2 CFAP73 TPPP2 IFT81 CNTRL KIAA0586 MET RAB28 STX3 TUBA1A ATP6V1D DNAH5 CCDC65 DNAH9 | 2.19e-03 | 898 | 151 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | bBAF complex | 2.25e-03 | 10 | 151 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | centriolar satellite | 2.39e-03 | 128 | 151 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.47e-03 | 78 | 151 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | ATPase complex | 2.47e-03 | 129 | 151 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | mismatch repair complex | 2.73e-03 | 11 | 151 | 2 | GO:0032300 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.82e-03 | 133 | 151 | 5 | GO:0005881 | |
| GeneOntologyCellularComponent | outer dynein arm | 3.26e-03 | 12 | 151 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase, V1 domain | 3.26e-03 | 12 | 151 | 2 | GO:0000221 | |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase, V1 domain | 3.26e-03 | 12 | 151 | 2 | GO:0033180 | |
| MousePheno | muscle hypoplasia | 4.98e-06 | 15 | 112 | 4 | MP:0000734 | |
| MousePheno | enlarged brain ventricles | 3.58e-05 | 156 | 112 | 8 | MP:0011380 | |
| MousePheno | abnormal brain ventricle size | 5.11e-05 | 164 | 112 | 8 | MP:0013229 | |
| Domain | Alpha_tubulin | 1.43e-11 | 9 | 142 | 6 | IPR002452 | |
| Domain | - | 6.17e-09 | 20 | 142 | 6 | 3.30.1330.20 | |
| Domain | - | 8.58e-09 | 21 | 142 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.17e-08 | 22 | 142 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.17e-08 | 22 | 142 | 6 | IPR018316 | |
| Domain | - | 1.17e-08 | 22 | 142 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.17e-08 | 22 | 142 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.58e-08 | 23 | 142 | 6 | IPR008280 | |
| Domain | Tubulin_C | 1.58e-08 | 23 | 142 | 6 | IPR023123 | |
| Domain | TUBULIN | 1.58e-08 | 23 | 142 | 6 | PS00227 | |
| Domain | Tubulin | 1.58e-08 | 23 | 142 | 6 | IPR000217 | |
| Domain | Tubulin | 1.58e-08 | 23 | 142 | 6 | SM00864 | |
| Domain | Tubulin_CS | 1.58e-08 | 23 | 142 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.09e-08 | 24 | 142 | 6 | IPR003008 | |
| Domain | Tubulin | 2.09e-08 | 24 | 142 | 6 | PF00091 | |
| Domain | TMEM183 | 5.74e-05 | 2 | 142 | 2 | IPR026509 | |
| Domain | MutL_C | 5.74e-05 | 2 | 142 | 2 | IPR014790 | |
| Domain | MutL_C | 5.74e-05 | 2 | 142 | 2 | PF08676 | |
| Domain | MutL_C | 5.74e-05 | 2 | 142 | 2 | SM00853 | |
| Domain | Dynein_HC_stalk | 1.47e-04 | 14 | 142 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.47e-04 | 14 | 142 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.47e-04 | 14 | 142 | 3 | PF08393 | |
| Domain | MT | 1.47e-04 | 14 | 142 | 3 | PF12777 | |
| Domain | DHC_fam | 1.83e-04 | 15 | 142 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.83e-04 | 15 | 142 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.83e-04 | 15 | 142 | 3 | IPR004273 | |
| Domain | Actin_CS | 2.24e-04 | 16 | 142 | 3 | IPR004001 | |
| Domain | P-loop_NTPase | DNHD1 MYH2 RAB25 EP400 CHD8 IQCN GFM2 RAB28 KIF15 SMARCA2 NLRC5 MYH15 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 2.47e-04 | 848 | 142 | 17 | IPR027417 |
| Domain | ACTINS_2 | 2.71e-04 | 17 | 142 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 3.23e-04 | 18 | 142 | 3 | IPR020902 | |
| Domain | HSA | 3.41e-04 | 4 | 142 | 2 | SM00573 | |
| Domain | HSA | 3.41e-04 | 4 | 142 | 2 | PS51204 | |
| Domain | DNA_MISMATCH_REPAIR_1 | 3.41e-04 | 4 | 142 | 2 | PS00058 | |
| Domain | DNA_mismatch_repair_C | 3.41e-04 | 4 | 142 | 2 | IPR013507 | |
| Domain | DNA_mismatch_repair_fam | 3.41e-04 | 4 | 142 | 2 | IPR002099 | |
| Domain | DNA_mis_repair | 3.41e-04 | 4 | 142 | 2 | PF01119 | |
| Domain | HSA_dom | 3.41e-04 | 4 | 142 | 2 | IPR014012 | |
| Domain | HSA | 3.41e-04 | 4 | 142 | 2 | PF07529 | |
| Domain | ACTINS_ACT_LIKE | 3.81e-04 | 19 | 142 | 3 | PS01132 | |
| Domain | DNA_mismatch_repair_CS | 5.65e-04 | 5 | 142 | 2 | IPR014762 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 5.96e-04 | 22 | 142 | 3 | IPR014721 | |
| Domain | BRK | 8.44e-04 | 6 | 142 | 2 | SM00592 | |
| Domain | BRK_domain | 8.44e-04 | 6 | 142 | 2 | IPR006576 | |
| Domain | BRK | 8.44e-04 | 6 | 142 | 2 | PF07533 | |
| Domain | Ank_2 | 1.30e-03 | 215 | 142 | 7 | PF12796 | |
| Domain | DHC_N1 | 1.56e-03 | 8 | 142 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.56e-03 | 8 | 142 | 2 | IPR013594 | |
| Domain | Actin | 1.65e-03 | 31 | 142 | 3 | IPR004000 | |
| Domain | Actin | 1.65e-03 | 31 | 142 | 3 | PF00022 | |
| Domain | ACTIN | 1.65e-03 | 31 | 142 | 3 | SM00268 | |
| Domain | SNF2_N | 1.82e-03 | 32 | 142 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.82e-03 | 32 | 142 | 3 | PF00176 | |
| Domain | SynN | 2.00e-03 | 9 | 142 | 2 | SM00503 | |
| Domain | Ribosomal_S5_D2-typ_fold | 2.17e-03 | 34 | 142 | 3 | IPR020568 | |
| Domain | Leu-rich_rpt_4 | 2.48e-03 | 10 | 142 | 2 | IPR025875 | |
| Domain | LRR_4 | 2.48e-03 | 10 | 142 | 2 | PF12799 | |
| Domain | - | 2.91e-03 | 248 | 142 | 7 | 1.25.40.20 | |
| Domain | Syntaxin | 3.02e-03 | 11 | 142 | 2 | PF00804 | |
| Domain | MBD | 3.02e-03 | 11 | 142 | 2 | SM00391 | |
| Domain | MBD | 3.02e-03 | 11 | 142 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 3.02e-03 | 11 | 142 | 2 | IPR001739 | |
| Domain | MBD | 3.02e-03 | 11 | 142 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 3.02e-03 | 11 | 142 | 2 | IPR016177 | |
| Domain | Cation/H_exchanger_CPA1 | 3.02e-03 | 11 | 142 | 2 | IPR018422 | |
| Domain | ANK | 3.12e-03 | 251 | 142 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 3.25e-03 | 253 | 142 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.33e-03 | 254 | 142 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.33e-03 | 254 | 142 | 7 | PS50297 | |
| Domain | Syntaxin_N | 3.60e-03 | 12 | 142 | 2 | IPR006011 | |
| Domain | Ras | 3.84e-03 | 136 | 142 | 5 | PF00071 | |
| Domain | Ankyrin_rpt | 3.94e-03 | 262 | 142 | 7 | IPR002110 | |
| Domain | MIRO-like | 4.24e-03 | 13 | 142 | 2 | IPR013684 | |
| Domain | Roc | 4.24e-03 | 13 | 142 | 2 | PF08477 | |
| Domain | - | DNHD1 RAB25 EP400 CHD8 GFM2 RAB28 SMARCA2 NLRC5 DNAH5 DNAH9 RHOF AGAP1 AGAP3 | 4.56e-03 | 746 | 142 | 13 | 3.40.50.300 |
| Domain | Dynein_heavy_chain_D4_dom | 4.92e-03 | 14 | 142 | 2 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 4.92e-03 | 14 | 142 | 2 | IPR011704 | |
| Domain | Na_H_Exchanger | 4.92e-03 | 14 | 142 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 4.92e-03 | 14 | 142 | 2 | IPR006153 | |
| Domain | AAA_8 | 4.92e-03 | 14 | 142 | 2 | PF12780 | |
| Domain | AAA_5 | 4.92e-03 | 14 | 142 | 2 | PF07728 | |
| Domain | IQ | 5.54e-03 | 93 | 142 | 4 | PS50096 | |
| Domain | Myosin_N | 5.65e-03 | 15 | 142 | 2 | PF02736 | |
| Domain | Myosin_N | 5.65e-03 | 15 | 142 | 2 | IPR004009 | |
| Domain | Laminin_N | 6.42e-03 | 16 | 142 | 2 | IPR008211 | |
| Domain | Syntaxin/epimorphin_CS | 6.42e-03 | 16 | 142 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 6.42e-03 | 16 | 142 | 2 | PS00914 | |
| Domain | LamNT | 6.42e-03 | 16 | 142 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 6.42e-03 | 16 | 142 | 2 | PS51117 | |
| Domain | Laminin_N | 6.42e-03 | 16 | 142 | 2 | PF00055 | |
| Domain | Small_GTPase | 7.59e-03 | 160 | 142 | 5 | IPR001806 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.32e-11 | 17 | 108 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A DNAH5 DNAH9 | 2.94e-11 | 43 | 108 | 9 | M47669 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.78e-11 | 18 | 108 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A DNAH5 DNAH9 | 4.56e-11 | 45 | 108 | 9 | M47670 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.94e-11 | 19 | 108 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.94e-11 | 19 | 108 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 9.09e-11 | 20 | 108 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 9.09e-11 | 20 | 108 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.35e-10 | 21 | 108 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.35e-10 | 21 | 108 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.97e-10 | 22 | 108 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 2.82e-10 | 23 | 108 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.82e-10 | 23 | 108 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.82e-10 | 23 | 108 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 3.96e-10 | 24 | 108 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.96e-10 | 24 | 108 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 5.46e-10 | 25 | 108 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.46e-10 | 25 | 108 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 7.43e-10 | 26 | 108 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.43e-10 | 26 | 108 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.32e-09 | 28 | 108 | 7 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.73e-09 | 29 | 108 | 7 | M27948 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.17e-09 | 49 | 108 | 8 | M891 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 3.66e-09 | 32 | 108 | 7 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.66e-09 | 32 | 108 | 7 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 4.61e-09 | 33 | 108 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 4.61e-09 | 33 | 108 | 7 | M47901 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.08e-09 | 53 | 108 | 8 | M27651 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.17e-09 | 35 | 108 | 7 | M47774 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 8.25e-09 | 55 | 108 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 9.56e-09 | 56 | 108 | 8 | M2333 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.32e-08 | 38 | 108 | 7 | M14981 | |
| Pathway | REACTOME_KINESINS | 1.92e-08 | 61 | 108 | 8 | M977 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 3.27e-08 | 43 | 108 | 7 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 3.86e-08 | 44 | 108 | 7 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.86e-08 | 44 | 108 | 7 | M27934 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 5.33e-08 | 46 | 108 | 7 | M27828 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.28e-08 | 72 | 108 | 8 | M26954 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.12e-07 | 51 | 108 | 7 | M26972 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.12e-07 | 76 | 108 | 8 | M48037 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.38e-07 | 17 | 108 | 5 | MM14731 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.68e-07 | 54 | 108 | 7 | M27482 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.46e-07 | 57 | 108 | 7 | M27251 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.89e-07 | 94 | 108 | 8 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 6.39e-07 | 95 | 108 | 8 | M6729 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B KIF15 TUBA1A | 8.54e-07 | 134 | 108 | 9 | M27751 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.48e-07 | 100 | 108 | 8 | M27650 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.13e-06 | 71 | 108 | 7 | M39690 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.66e-06 | 48 | 108 | 6 | MM15353 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.70e-06 | 27 | 108 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.70e-06 | 27 | 108 | 5 | MM15674 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.80e-06 | 76 | 108 | 7 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.35e-06 | 79 | 108 | 7 | M27743 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.47e-06 | 29 | 108 | 5 | MM15219 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.69e-06 | 52 | 108 | 6 | MM15211 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | CAMK4 TUBA3D IFT81 TUBA1C CNTRL TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A IMMT CRTC2 | 2.81e-06 | 297 | 108 | 12 | M27050 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.02e-06 | 121 | 108 | 8 | M872 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.11e-06 | 32 | 108 | 5 | MM14730 | |
| Pathway | REACTOME_KINESINS | 4.65e-06 | 57 | 108 | 6 | MM15714 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 5.43e-06 | 126 | 108 | 8 | M705 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.64e-06 | 90 | 108 | 7 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 5.64e-06 | 90 | 108 | 7 | M4013 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.76e-06 | 127 | 108 | 8 | M27181 | |
| Pathway | REACTOME_AGGREPHAGY | 7.50e-06 | 36 | 108 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.62e-06 | 37 | 108 | 5 | MM15102 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 9.94e-06 | 98 | 108 | 7 | M776 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.10e-05 | 66 | 108 | 6 | MM17074 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.18e-05 | 140 | 108 | 8 | M27550 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.29e-05 | 102 | 108 | 7 | M27648 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.44e-05 | 20 | 108 | 4 | MM1383 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.05e-05 | 151 | 108 | 8 | M550 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.06e-05 | 44 | 108 | 5 | MM14606 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3D IFT81 TUBA1C CNTRL TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A | 2.36e-05 | 201 | 108 | 9 | M27472 |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C BICD1 TUBA1B KIF15 TUBA1A | 2.55e-05 | 203 | 108 | 9 | M27654 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.59e-05 | 156 | 108 | 8 | M27097 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3D TUBA1C CNTRL TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A MAD1L1 | 2.65e-05 | 204 | 108 | 9 | M4217 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CACNA2D2 CAMK4 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B STX1A TUBA1A | 4.18e-05 | 270 | 108 | 10 | M15514 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.69e-05 | 52 | 108 | 5 | MM14949 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 4.80e-05 | 170 | 108 | 8 | M941 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 6.52e-05 | 131 | 108 | 7 | MM15497 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.29e-05 | 94 | 108 | 6 | MM14515 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 9.06e-05 | 138 | 108 | 7 | M29805 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 9.38e-05 | 187 | 108 | 8 | M961 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.05e-04 | 98 | 108 | 6 | MM15352 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.09e-04 | 191 | 108 | 8 | M29614 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CDC42BPA RBBP6 TUBA3D TUBA1C STMN2 TUBA3E NCK1 TUBA4A TUBA3C TUBA1B POTEE TUBA1A MACO1 MAD1L1 PREX1 RHOF | 1.14e-04 | 720 | 108 | 16 | M41838 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.49e-04 | 200 | 108 | 8 | M864 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.71e-04 | 68 | 108 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.71e-04 | 68 | 108 | 5 | MM14968 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.77e-04 | 205 | 108 | 8 | M752 | |
| Pathway | REACTOME_AUTOPHAGY | 2.10e-04 | 158 | 108 | 7 | M27935 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.29e-04 | 113 | 108 | 6 | M27471 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.39e-04 | 73 | 108 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.39e-04 | 73 | 108 | 5 | MM15672 | |
| Pathway | REACTOME_HCMV_INFECTION | 2.45e-04 | 162 | 108 | 7 | M29804 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.64e-04 | 116 | 108 | 6 | MM14855 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.64e-04 | 116 | 108 | 6 | MM15715 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 3.28e-04 | 18 | 108 | 3 | M225 | |
| Pathway | WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME | 3.28e-04 | 18 | 108 | 3 | M45539 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 4.58e-04 | 236 | 108 | 8 | M27185 | |
| Pubmed | 9.03e-16 | 9 | 151 | 7 | 21167302 | ||
| Pubmed | 1.22e-12 | 19 | 151 | 7 | 15698476 | ||
| Pubmed | 1.22e-12 | 19 | 151 | 7 | 15691386 | ||
| Pubmed | 4.08e-12 | 22 | 151 | 7 | 28117675 | ||
| Pubmed | 8.63e-12 | 6 | 151 | 5 | 3785200 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 8.00e-11 | 8 | 151 | 5 | 16148047 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | EXOSC10 EP400 POTEF TUBA1C CHD8 TUBA4A TUBA3C TASOR2 TUBA1B POTEE TUBA1A ZNF638 POTEI | 2.25e-10 | 271 | 151 | 13 | 32433965 |
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 18400243 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.27e-10 | 22 | 151 | 6 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.12e-09 | 12 | 151 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.81e-09 | 13 | 151 | 5 | 10908577 | |
| Pubmed | 2.80e-09 | 14 | 151 | 5 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 5.09e-09 | 6 | 151 | 4 | 7651436 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 16327313 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | LYRM7 DDR1 TUT4 RAB25 CDC42BPA CACNA2D2 WDR70 TMEM183BP IQCN SKI TASOR2 BICD1 SH3BP4 RAB28 STX3 CDK13 KIAA1217 ZNF589 MAD1L1 SMARCA2 ZNF638 NLRC5 CSMD1 AGAP1 AGAP3 | 6.59e-09 | 1489 | 151 | 25 | 28611215 |
| Pubmed | 8.56e-09 | 17 | 151 | 5 | 17360745 | ||
| Pubmed | 1.18e-08 | 7 | 151 | 4 | 36681692 | ||
| Pubmed | 1.18e-08 | 7 | 151 | 4 | 11146551 | ||
| Pubmed | 3.58e-08 | 22 | 151 | 5 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 4.23e-08 | 9 | 151 | 4 | 11953448 | |
| Pubmed | POTEF TUBA3E TUBA4A TUBA3C TUBA1B POTEE KIF15 TUBA1A KIAA1217 LPL STK24 IMMT DSE RBM17 | 6.05e-08 | 513 | 151 | 14 | 25798074 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 11163133 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 8.02e-08 | 3 | 151 | 3 | 9722999 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EXOSC10 EP400 RBBP6 BAZ2B TUBA1C CHD8 KRR1 TUBA4A TASOR2 EEF1A1P5 TUBA1B RAD51AP1 ARID1B PRCC SUGP1 ZNF638 IMMT RBM17 | 1.95e-07 | 954 | 151 | 18 | 36373674 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EXOSC10 ORC6 TUBA1C CHD8 TUBA4A TUBA1B PRCC MAD1L1 SMARCA2 ZNF638 TLN2 DEPDC7 STK24 RBM17 | 2.80e-07 | 582 | 151 | 14 | 20467437 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP CDC42BPA EP400 PPP1R3B WDR70 CHD8 HDAC7 SH3BP4 CDR2L TDRD3 FAT1 CDK13 MAD1L1 NLRC5 TLN2 MAPKBP1 PREX1 RHOF AGAP3 | 3.59e-07 | 1105 | 151 | 19 | 35748872 |
| Pubmed | 4.09e-07 | 212 | 151 | 9 | 23463506 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 4.86e-07 | 67 | 151 | 6 | 34644545 | |
| Pubmed | VMP1 CDC42BPA EP400 RBBP6 TUBA1C CHD8 KRR1 ERLIN1 DNAJC2 EEF1A1P5 CNOT6 TUBA1B POTEE TDRD3 CDK13 MACO1 KAT8 SMARCA2 PREX1 IMMT AGAP1 AGAP3 | 5.73e-07 | 1497 | 151 | 22 | 31527615 | |
| Pubmed | SATB2 CDC42BPA EP400 RBBP6 CHD8 KRR1 SKI FHAD1 SETDB1 FAT1 ARID1B RESF1 PRCC KAT8 MRPS15 SUGP1 SMARCA2 ZNF638 ASXL2 IMMT LRIF1 | 1.06e-06 | 1429 | 151 | 21 | 35140242 | |
| Pubmed | EXOSC10 SATB2 EP400 BAZ2B ORC6 CHD8 CCDC7 ARID1B RESF1 CDK13 KAT8 SUGP1 SMARCA2 ASXL2 TXLNG LRIF1 RPL9 RBM17 | 1.57e-06 | 1103 | 151 | 18 | 34189442 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 18613978 | ||
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 12090300 | ||
| Pubmed | EXOSC10 CDC42BPA EP400 CAMK4 TUBA1C CNTRL TASOR2 SH3BP4 MET FAT1 ZNF638 DEPDC7 RPL9 AGAP1 AGAP3 | 1.64e-06 | 777 | 151 | 15 | 35844135 | |
| Pubmed | TUT4 EP400 RIBC2 RBBP6 CHD8 SKI C2CD5 RAD51AP1 SETDB1 FAT1 ARID1B MLH3 RESF1 ZNF589 SCAPER SMARCA2 CSMD1 AGAP3 | 1.85e-06 | 1116 | 151 | 18 | 31753913 | |
| Pubmed | 1.93e-06 | 21 | 151 | 4 | 36332009 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.96e-06 | 256 | 151 | 9 | 24189400 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | CDC42BPA EP400 BAZ2B TUBA1C CHD8 TASOR2 EEF1A1P5 TUBA1B RPS19BP1 SMARCA2 ZNF638 | 2.01e-06 | 411 | 151 | 11 | 35182466 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.43e-06 | 351 | 151 | 10 | 38297188 | |
| Pubmed | 3.60e-06 | 94 | 151 | 6 | 36584595 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.44e-06 | 283 | 151 | 9 | 30585729 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP IFT81 WDR70 HDAC7 TUBA3C ERLIN1 SH3BP4 CNOT6 CDR2L SETDB1 RAB28 PRCC ZNF638 TXLNG IMMT CRTC2 AGAP1 DNPEP AGAP3 | 4.94e-06 | 1321 | 151 | 19 | 27173435 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 5.11e-06 | 288 | 151 | 9 | 31501420 | |
| Pubmed | Transport of the outer dynein arm complex to cilia requires a cytoplasmic protein Lrrc6. | 6.61e-06 | 9 | 151 | 3 | 27353389 | |
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 19103752 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNHD1 TUT4 RAB25 CDC42BPA CAMK4 SH3BP4 FAT1 ATP6V1H STX3 TUBA1A ATP6V1D SCARB2 STK24 RHOF KNG1 CRTC2 | 9.65e-06 | 1016 | 151 | 16 | 19056867 |
| Pubmed | EXOSC10 SATB2 EP400 TUBA1C ARID1B RESF1 TUBA1A MRPS15 SUGP1 RBM17 | 9.86e-06 | 396 | 151 | 10 | 26687479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 RBBP6 POTEE SETDB1 TDRD3 RESF1 KIF15 TUBA1A MACO1 KIAA1217 POTEI LRIF1 | 1.09e-05 | 588 | 151 | 12 | 38580884 |
| Pubmed | 1.12e-05 | 67 | 151 | 5 | 30669930 | ||
| Pubmed | POTEF TUBA1C TUBA3E CHD8 KRR1 TUBA4A EEF1A1P5 TUBA1B POTEE ARID1B TUBA1A CDK13 MRPS15 POTEI IMMT RPL9 GOT2 | 1.18e-05 | 1153 | 151 | 17 | 29845934 | |
| Pubmed | EXOSC10 RBBP6 CAMK4 TUBA1C KRR1 TUBA4A ERLIN1 TASOR2 SH3BP4 POTEE MRPS15 | 1.19e-05 | 496 | 151 | 11 | 31343991 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 1.29e-05 | 11 | 151 | 3 | 20405035 | |
| Pubmed | Identification of proteins that interact with alpha A-crystallin using a human proteome microarray. | 1.34e-05 | 118 | 151 | 6 | 24453475 | |
| Pubmed | DAB2IP PMS2 RBBP6 CHD8 SH3BP4 CDK13 MAD1L1 ZNF638 TLN2 TXLNG AGAP3 | 1.35e-05 | 503 | 151 | 11 | 16964243 | |
| Pubmed | DAB2IP TUT4 TUBA1C TUBA3E DNAJC2 TUBA1B SNX6 TUBA1A TXLNG RPL9 | 1.36e-05 | 411 | 151 | 10 | 36652389 | |
| Pubmed | SATB2 EP400 RBBP6 POTEF TUBA1C WDR70 PRCC CDK13 SUGP1 POTEI RBM17 | 1.43e-05 | 506 | 151 | 11 | 30890647 | |
| Pubmed | 1.61e-05 | 35 | 151 | 4 | 22688191 | ||
| Pubmed | MYH2 PYROXD1 POTEF IFT81 CNTRL SKI ERLIN1 TASOR2 POTEE RAD51AP1 STX3 CDK13 NFXL1 MYH15 POTEI PREX1 IMMT TBX1 RPL9 | 1.69e-05 | 1442 | 151 | 19 | 35575683 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.86e-05 | 125 | 151 | 6 | 36030824 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 33453991 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 1.87e-05 | 2 | 151 | 2 | 37676945 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.87e-05 | 2 | 151 | 2 | 24268707 | |
| Pubmed | Functional cooperation between the proteins Nck and ADAP is fundamental for actin reorganization. | 1.87e-05 | 2 | 151 | 2 | 21536650 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.87e-05 | 2 | 151 | 2 | 19669888 | |
| Pubmed | Myosin gene mutation correlates with anatomical changes in the human lineage. | 1.87e-05 | 2 | 151 | 2 | 15042088 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28547530 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25328666 | ||
| Pubmed | The adapter proteins ADAP and Nck cooperate in T cell adhesion. | 1.87e-05 | 2 | 151 | 2 | 24769494 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 12054644 | ||
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.87e-05 | 2 | 151 | 2 | 3839072 | |
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 1.87e-05 | 2 | 151 | 2 | 16644869 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27847402 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 33061433 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15806149 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22296162 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28867767 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.96e-05 | 341 | 151 | 9 | 32971831 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | LYRM7 EXOSC10 STMN2 ERLIN1 SNX6 KIAA1217 ATP6V1D SCAPER MRPS15 SMARCA2 TLN2 TXLNG IMMT RPL9 | 2.11e-05 | 847 | 151 | 14 | 35235311 |
| Pubmed | DAB2IP EXOSC10 PMS2 TMEM183A CNTRL TMEM183BP KRR1 ERLIN1 C2CD5 ARID1B RESF1 NFXL1 ZNF638 ASXL2 STK24 DSE | 2.13e-05 | 1084 | 151 | 16 | 11544199 | |
| Pubmed | 2.22e-05 | 13 | 151 | 3 | 14697242 | ||
| Pubmed | RIBC2 TUBA3D TUBA1C TUBA3E IQCN TUBA3C EEF1A1P5 TUBA1A RPL9 DNPEP | 2.34e-05 | 438 | 151 | 10 | 21630459 | |
| Pubmed | 2.41e-05 | 268 | 151 | 8 | 33640491 | ||
| Pubmed | 2.50e-05 | 39 | 151 | 4 | 21347282 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SATB2 EP400 TUBA1C WDR70 CHD8 TUBA3C EEF1A1P5 RESF1 PRCC SUGP1 | 2.63e-05 | 444 | 151 | 10 | 34795231 |
| Pubmed | Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. | 2.82e-05 | 14 | 151 | 3 | 17881575 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.07e-05 | 361 | 151 | 9 | 26167880 | |
| Pubmed | 3.37e-05 | 281 | 151 | 8 | 24163370 | ||
| Pubmed | Divergent and conserved roles of Dll1 signaling in development of craniofacial and trunk muscle. | 3.51e-05 | 15 | 151 | 3 | 25220152 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.51e-05 | 15 | 151 | 3 | 16824795 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | EXOSC10 RBBP6 TUBA1C KRR1 TUBA4A TUBA1B POTEE TDRD3 TUBA1A CDK13 RPS19BP1 CRTC2 | 4.36e-05 | 678 | 151 | 12 | 30209976 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DAB2IP WDR70 FHIP2A TUBA4A TUBA1B SETDB1 PRCC KIAA1217 SUGP1 DEPDC7 RHOF ATG16L2 CRTC2 AGAP1 RBM17 | 4.96e-05 | 1038 | 151 | 15 | 26673895 |
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 5.60e-05 | 3 | 151 | 2 | 12749852 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 31767681 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 12087096 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 29728365 | ||
| Pubmed | miR-23a promotes the transition from indolent to invasive colorectal cancer. | 5.60e-05 | 3 | 151 | 2 | 22628407 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 24122793 | ||
| Pubmed | Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons. | 5.60e-05 | 3 | 151 | 2 | 29317598 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 37369679 | ||
| Interaction | TCP11L2 interactions | 6.21e-09 | 21 | 145 | 6 | int:TCP11L2 | |
| Interaction | IFNE interactions | 1.28e-06 | 27 | 145 | 5 | int:IFNE | |
| Interaction | POTEB3 interactions | 4.91e-06 | 35 | 145 | 5 | int:POTEB3 | |
| Interaction | KLK11 interactions | 5.67e-06 | 36 | 145 | 5 | int:KLK11 | |
| Interaction | GRM7 interactions | 9.16e-06 | 19 | 145 | 4 | int:GRM7 | |
| Interaction | BRINP3 interactions | 2.89e-05 | 25 | 145 | 4 | int:BRINP3 | |
| Interaction | TXNDC9 interactions | 3.22e-05 | 124 | 145 | 7 | int:TXNDC9 | |
| Interaction | SIAH1 interactions | IQCN TUBA4A TUBA3C TUBA1B RAD51AP1 TUBA1A KIAA1217 RPS19BP1 MAPKBP1 | 3.49e-05 | 223 | 145 | 9 | int:SIAH1 |
| Interaction | ZC2HC1B interactions | 4.60e-05 | 28 | 145 | 4 | int:ZC2HC1B | |
| Interaction | LTA interactions | 4.60e-05 | 28 | 145 | 4 | int:LTA | |
| Interaction | PRTN3 interactions | 5.04e-05 | 91 | 145 | 6 | int:PRTN3 | |
| Interaction | LRRC25 interactions | 5.92e-05 | 185 | 145 | 8 | int:LRRC25 | |
| Interaction | GML interactions | 6.07e-05 | 58 | 145 | 5 | int:GML | |
| Interaction | CD81 interactions | RBBP6 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B STX1A TUBA1A IMMT | 7.02e-05 | 303 | 145 | 10 | int:CD81 |
| Interaction | TEX11 interactions | 7.22e-05 | 97 | 145 | 6 | int:TEX11 | |
| Interaction | PCM1 interactions | CCDC14 VMP1 CDKL2 IFT81 CNTRL KIAA0586 BICD1 KIF15 KIAA1217 SCARB2 CCDC65 TXLNG | 7.31e-05 | 434 | 145 | 12 | int:PCM1 |
| Interaction | CRYAA interactions | 7.68e-05 | 192 | 145 | 8 | int:CRYAA | |
| Interaction | NEK4 interactions | POTEF TUBA3E TUBA4A TUBA3C TUBA1B POTEE KIF15 TUBA1A KIAA1217 LPL STK24 IMMT DSE RBM17 | 8.14e-05 | 582 | 145 | 14 | int:NEK4 |
| Interaction | ZC2HC1A interactions | 9.75e-05 | 64 | 145 | 5 | int:ZC2HC1A | |
| Interaction | POTEC interactions | 9.90e-05 | 13 | 145 | 3 | int:POTEC | |
| Interaction | CELA3A interactions | 1.01e-04 | 34 | 145 | 4 | int:CELA3A | |
| Interaction | SMC5 interactions | EXOSC10 EP400 RBBP6 BAZ2B TUBA1C CHD8 KRR1 HDAC7 TUBA4A TASOR2 EEF1A1P5 TUBA1B RAD51AP1 ARID1B PRCC SUGP1 ZNF638 IMMT RBM17 | 1.04e-04 | 1000 | 145 | 19 | int:SMC5 |
| Interaction | ALPI interactions | 1.21e-04 | 67 | 145 | 5 | int:ALPI | |
| Interaction | JPH4 interactions | 1.30e-04 | 68 | 145 | 5 | int:JPH4 | |
| Interaction | CDC5L interactions | EXOSC10 RBBP6 ORC6 TUBA1C CHD8 KRR1 TUBA4A TUBA1B PRCC MAD1L1 SMARCA2 ZNF638 TLN2 DEPDC7 STK24 RPL9 RBM17 | 1.44e-04 | 855 | 145 | 17 | int:CDC5L |
| Interaction | TRAC interactions | 1.56e-04 | 15 | 145 | 3 | int:TRAC | |
| Interaction | CAPSL interactions | 1.56e-04 | 15 | 145 | 3 | int:CAPSL | |
| Interaction | DLL1 interactions | 1.57e-04 | 38 | 145 | 4 | int:DLL1 | |
| Interaction | CD48 interactions | 1.74e-04 | 39 | 145 | 4 | int:CD48 | |
| Interaction | NANOG interactions | EXOSC10 SATB2 EP400 ARID1B RESF1 TUBA1A KIAA1217 KAT8 MAD1L1 SUGP1 SMARCA2 RBM17 | 1.91e-04 | 481 | 145 | 12 | int:NANOG |
| Cytoband | 2q21.1 | 1.43e-06 | 58 | 151 | 5 | 2q21.1 | |
| Cytoband | 12q13.12 | 7.61e-06 | 38 | 151 | 4 | 12q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.50e-04 | 151 | 151 | 5 | chr2q21 | |
| GeneFamily | Tubulins | 5.77e-11 | 26 | 96 | 7 | 778 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 5.14e-07 | 13 | 96 | 4 | 685 | |
| GeneFamily | Myosin heavy chains | 6.30e-05 | 15 | 96 | 3 | 1098 | |
| GeneFamily | MutL homologs | 1.66e-04 | 4 | 96 | 2 | 1027 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.49e-03 | 11 | 96 | 2 | 1025 | |
| GeneFamily | Laminin subunits | 1.78e-03 | 12 | 96 | 2 | 626 | |
| GeneFamily | Ankyrin repeat domain containing | 1.84e-03 | 242 | 96 | 6 | 403 | |
| GeneFamily | Syntaxins | 3.19e-03 | 16 | 96 | 2 | 818 | |
| GeneFamily | Dyneins, axonemal | 3.60e-03 | 17 | 96 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.60e-03 | 17 | 96 | 2 | 1291 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 6.01e-03 | 22 | 96 | 2 | 579 | |
| GeneFamily | V-type ATPases | 6.56e-03 | 23 | 96 | 2 | 415 | |
| GeneFamily | Cyclin dependent kinases | 8.35e-03 | 26 | 96 | 2 | 496 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SATB2 TUT4 CDC42BPA BAZ2B NCK1 C2CD5 DNAJC2 BICD1 SETDB1 TDRD3 FAT1 ATP6V1H CDK13 MAD1L1 SMARCA2 ZNF638 STK24 AGAP1 | 2.31e-06 | 856 | 151 | 18 | M4500 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 5.63e-06 | 166 | 151 | 8 | M6826 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SATB2 TUT4 CDC42BPA BAZ2B NCK1 C2CD5 FAT1 CDK13 SMARCA2 ZNF638 STK24 AGAP1 | 1.75e-05 | 466 | 151 | 12 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TUT4 CDC42BPA PYROXD1 BAZ2B KRR1 TASOR2 RAD51AP1 TDRD3 RESF1 KIF15 SMARCA2 ZNF638 FYB1 RBM17 | 2.79e-05 | 656 | 151 | 14 | M18979 |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 3.80e-05 | 33 | 151 | 4 | M7409 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.96e-07 | 198 | 151 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 4.27e-07 | 200 | 151 | 8 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.69e-06 | 167 | 151 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 177 | 151 | 7 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 177 | 151 | 7 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.98e-06 | 182 | 151 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.24e-06 | 192 | 151 | 7 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 195 | 151 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.86e-06 | 196 | 151 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.86e-06 | 196 | 151 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 197 | 151 | 7 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-06 | 198 | 151 | 7 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-06 | 198 | 151 | 7 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 198 | 151 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.37e-06 | 199 | 151 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.37e-06 | 199 | 151 | 7 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-06 | 200 | 151 | 7 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 148 | 151 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 148 | 151 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-05 | 158 | 151 | 6 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 167 | 151 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.87e-05 | 174 | 151 | 6 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.97e-05 | 175 | 151 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 3.58e-05 | 181 | 151 | 6 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 3.58e-05 | 181 | 151 | 6 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.70e-05 | 182 | 151 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 184 | 151 | 6 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 184 | 151 | 6 | d5b8604142ae70abbfa4ea881ce55b2a3a2a46a6 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.17e-05 | 186 | 151 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Ciliated-cil-1|World / Class top | 4.17e-05 | 186 | 151 | 6 | 283de646a0e8a322c42a714ae19db9918011146e | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.17e-05 | 186 | 151 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 4.43e-05 | 188 | 151 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 188 | 151 | 6 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 189 | 151 | 6 | a6c62b456982067ad4d224a2efa3919969000693 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-05 | 189 | 151 | 6 | a28e0922e10013ae79266f6a3f9305e6ee614d8b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 189 | 151 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 189 | 151 | 6 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 4.56e-05 | 189 | 151 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.70e-05 | 190 | 151 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.70e-05 | 190 | 151 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.70e-05 | 190 | 151 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 191 | 151 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.84e-05 | 191 | 151 | 6 | 3e84c453e8a151c42808fe2935f1d732e180008c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-05 | 191 | 151 | 6 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 4.84e-05 | 191 | 151 | 6 | aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-05 | 191 | 151 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.84e-05 | 191 | 151 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-05 | 191 | 151 | 6 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-05 | 192 | 151 | 6 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 4.98e-05 | 192 | 151 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 5.12e-05 | 193 | 151 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 194 | 151 | 6 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 194 | 151 | 6 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.27e-05 | 194 | 151 | 6 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.27e-05 | 194 | 151 | 6 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 194 | 151 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 195 | 151 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-05 | 195 | 151 | 6 | 82561f6ed75ee33c2581fb25bd0997a9f0538cd8 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 5.43e-05 | 195 | 151 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 195 | 151 | 6 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 195 | 151 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 195 | 151 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.43e-05 | 195 | 151 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-05 | 196 | 151 | 6 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.58e-05 | 196 | 151 | 6 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.58e-05 | 196 | 151 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-05 | 196 | 151 | 6 | 1386003f5d885f0ea080934f7e05fe05f142a3d5 | |
| ToppCell | control-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.58e-05 | 196 | 151 | 6 | 10d914f1612622f64ac71da04e1995a854a4bec9 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.58e-05 | 196 | 151 | 6 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.74e-05 | 197 | 151 | 6 | 04aaf35ef4db6325b2b2b92e93272f1973764b78 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.74e-05 | 197 | 151 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.74e-05 | 197 | 151 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 198 | 151 | 6 | f6472649cf000918b98126cf02821d6779643292 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-05 | 198 | 151 | 6 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-05 | 198 | 151 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 198 | 151 | 6 | cd1cd0ac2a66578aa38a139322295170002ec049 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 198 | 151 | 6 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 198 | 151 | 6 | a17eb0e19e04e9d4fe14e19452d79c3c4559817a | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 5.91e-05 | 198 | 151 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.91e-05 | 198 | 151 | 6 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-05 | 198 | 151 | 6 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 5.91e-05 | 198 | 151 | 6 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-05 | 198 | 151 | 6 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 6.07e-05 | 199 | 151 | 6 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.07e-05 | 199 | 151 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-05 | 199 | 151 | 6 | 7816ad127b16208b1046da53f4a295b4a747b4cc | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 6.07e-05 | 199 | 151 | 6 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.07e-05 | 199 | 151 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-CD4_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.07e-05 | 199 | 151 | 6 | 992bc4f0dc4189f18773c55976eb124c3827e08b | |
| Drug | Epothilone D | 8.28e-09 | 12 | 148 | 5 | DB01873 | |
| Drug | Epothilone B | 8.28e-09 | 12 | 148 | 5 | DB03010 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.07e-06 | 4 | 148 | 3 | DB07574 | |
| Drug | 2-phenyl-4-quinolone | 2.59e-06 | 34 | 148 | 5 | CID000161091 | |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A | 6.39e-06 | 199 | 148 | 9 | 5810_UP | |
| Drug | bromocolchicine | 9.41e-06 | 21 | 148 | 4 | CID000161518 | |
| Drug | colchifoline | 9.41e-06 | 21 | 148 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 9.41e-06 | 21 | 148 | 4 | CID000164454 | |
| Drug | SRI-3072 | 9.41e-06 | 21 | 148 | 4 | CID000493469 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.14e-05 | 22 | 148 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 1.14e-05 | 22 | 148 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.14e-05 | 22 | 148 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 1.14e-05 | 22 | 148 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.14e-05 | 22 | 148 | 4 | CID000023759 | |
| Drug | NSC-339672 | 1.14e-05 | 22 | 148 | 4 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.38e-05 | 23 | 148 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 1.38e-05 | 23 | 148 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 1.38e-05 | 23 | 148 | 4 | CID000125548 | |
| Drug | NSC-373301 | 1.38e-05 | 23 | 148 | 4 | CID000341375 | |
| Drug | NSC355636 | 1.38e-05 | 23 | 148 | 4 | CID000100176 | |
| Drug | IKP104 | 1.38e-05 | 23 | 148 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.38e-05 | 23 | 148 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.38e-05 | 23 | 148 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.38e-05 | 23 | 148 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.38e-05 | 23 | 148 | 4 | CID000097865 | |
| Drug | parbendazole | 1.65e-05 | 24 | 148 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 1.65e-05 | 24 | 148 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.65e-05 | 24 | 148 | 4 | CID000330401 | |
| Drug | NABV | 1.65e-05 | 24 | 148 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 1.65e-05 | 24 | 148 | 4 | CID000163705 | |
| Drug | moscatilin | 1.65e-05 | 24 | 148 | 4 | CID000176096 | |
| Drug | NSC-36768 | 1.65e-05 | 24 | 148 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.65e-05 | 24 | 148 | 4 | CID000014995 | |
| Drug | colchicide | 1.65e-05 | 24 | 148 | 4 | CID000120712 | |
| Drug | mpMap | 1.95e-05 | 25 | 148 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 1.95e-05 | 25 | 148 | 4 | CID000160263 | |
| Drug | allocolchicine | 1.95e-05 | 25 | 148 | 4 | CID000196989 | |
| Drug | 1069C85 | 1.95e-05 | 25 | 148 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 1.95e-05 | 25 | 148 | 4 | CID006438440 | |
| Drug | MDL 27048 | 1.95e-05 | 25 | 148 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 1.95e-05 | 25 | 148 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.95e-05 | 25 | 148 | 4 | CID000043264 | |
| Drug | CA1P | 1.95e-05 | 25 | 148 | 4 | CID006918545 | |
| Drug | peloruside A | 1.95e-05 | 25 | 148 | 4 | CID006918506 | |
| Drug | NSC142227 | 1.95e-05 | 25 | 148 | 4 | CID000073427 | |
| Drug | TK-B | 2.00e-05 | 51 | 148 | 5 | CID000009074 | |
| Drug | NSC527981 | 2.29e-05 | 26 | 148 | 4 | CID000352796 | |
| Drug | NSC332029 | 2.29e-05 | 26 | 148 | 4 | CID000100073 | |
| Drug | indibulin | 2.29e-05 | 26 | 148 | 4 | CID000002929 | |
| Drug | pironetin | 2.29e-05 | 26 | 148 | 4 | CID006438891 | |
| Drug | isaxonine | 2.29e-05 | 26 | 148 | 4 | CID000071169 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 2.50e-05 | 181 | 148 | 8 | 1791_DN | |
| Drug | AC1L1J4H | 2.68e-05 | 27 | 148 | 4 | CID000004862 | |
| Drug | dinitroanilines | 2.68e-05 | 27 | 148 | 4 | CID000136400 | |
| Drug | NSC292222 | 2.68e-05 | 27 | 148 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 2.68e-05 | 27 | 148 | 4 | CID000178028 | |
| Drug | NSC 370147 | 3.11e-05 | 28 | 148 | 4 | CID000182762 | |
| Drug | NSC72302 | 3.11e-05 | 28 | 148 | 4 | CID000118078 | |
| Drug | 2,5-hexanedione | 3.17e-05 | 56 | 148 | 5 | CID000008035 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.53e-05 | 190 | 148 | 8 | 1483_UP | |
| Drug | bp U | 3.59e-05 | 29 | 148 | 4 | CID000368697 | |
| Drug | oxibendazole | 3.59e-05 | 29 | 148 | 4 | CID000004622 | |
| Drug | Aids106696 | 3.59e-05 | 29 | 148 | 4 | CID006475933 | |
| Drug | ddGDP | 3.59e-05 | 29 | 148 | 4 | CID000134739 | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.81e-05 | 192 | 148 | 8 | 4496_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.95e-05 | 193 | 148 | 8 | 6716_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.10e-05 | 194 | 148 | 8 | 3274_DN | |
| Drug | AC1NBBHE | 4.12e-05 | 30 | 148 | 4 | CID004490620 | |
| Drug | eleutherobin | 4.12e-05 | 30 | 148 | 4 | CID006918335 | |
| Drug | azatoxin | 4.12e-05 | 30 | 148 | 4 | CID000125383 | |
| Drug | NSC617668 | 4.12e-05 | 30 | 148 | 4 | CID000357989 | |
| Drug | citostal | 4.12e-05 | 30 | 148 | 4 | CID000018991 | |
| Drug | thiocolchicine | 4.12e-05 | 30 | 148 | 4 | CID000017648 | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 4.25e-05 | 195 | 148 | 8 | 4614_DN | |
| Drug | NSC3096 | 4.39e-05 | 98 | 148 | 6 | CID000002832 | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 3342_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 6867_UP | |
| Drug | NSC609395 | 4.71e-05 | 31 | 148 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 4.71e-05 | 31 | 148 | 4 | CID000100524 | |
| Drug | AC7700 | 4.71e-05 | 31 | 148 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 4.71e-05 | 31 | 148 | 4 | CID000032851 | |
| Drug | tropone | 4.71e-05 | 31 | 148 | 4 | CID000010881 | |
| Drug | AC1L3V8I | 4.71e-05 | 31 | 148 | 4 | CID000122777 | |
| Drug | NSC332598 | 4.71e-05 | 31 | 148 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 4.71e-05 | 31 | 148 | 4 | CID000023678 | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 6428_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 148 | 8 | 2677_DN | |
| Drug | AC1L1G95 | 5.35e-05 | 32 | 148 | 4 | CID000003583 | |
| Drug | NSC153858 | 5.35e-05 | 32 | 148 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 5.35e-05 | 32 | 148 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 5.35e-05 | 32 | 148 | 4 | CID000023757 | |
| Drug | mebendazole | 6.06e-05 | 33 | 148 | 4 | CID000004030 | |
| Drug | CA4P | 6.06e-05 | 33 | 148 | 4 | CID000370232 | |
| Drug | taltobulin | 6.06e-05 | 33 | 148 | 4 | CID006918637 | |
| Drug | PIPES | 6.07e-05 | 64 | 148 | 5 | CID000079723 | |
| Drug | triethyllead | 6.83e-05 | 34 | 148 | 4 | CID006328106 | |
| Drug | NSC376450 | 6.83e-05 | 34 | 148 | 4 | CID000005605 | |
| Drug | discodermolide | 7.67e-05 | 35 | 148 | 4 | CID000643668 | |
| Drug | AC1O5Y0F | 9.58e-05 | 37 | 148 | 4 | CID006442852 | |
| Drug | DTAF | 9.58e-05 | 37 | 148 | 4 | CID000123934 | |
| Disease | microlissencephaly (implicated_via_orthology) | 4.10e-16 | 8 | 142 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 4.10e-16 | 8 | 142 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 4.10e-16 | 8 | 142 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 4.22e-11 | 27 | 142 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | platelet component distribution width | VMP1 ATP23 CFAP73 TUBA1C NCK1 SKI HDAC7 TUBA4A C2CD5 LPL SUGP1 DEPDC7 FYB1 PREX1 RHOF | 3.89e-06 | 755 | 142 | 15 | EFO_0007984 |
| Disease | papillary renal cell carcinoma (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:4465 (is_implicated_in) | |
| Disease | RENAL CELL CARCINOMA, PAPILLARY, 1 | 2.30e-05 | 2 | 142 | 2 | 605074 | |
| Disease | Papillary renal cell carcinoma type 1 | 2.30e-05 | 2 | 142 | 2 | cv:C1336839 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 7.17e-05 | 46 | 142 | 4 | EFO_0005325, HP_0012735 | |
| Disease | Neoplasm of the genitourinary tract | 2.05e-04 | 24 | 142 | 3 | cv:C0042065 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 2.17e-04 | 61 | 142 | 4 | DOID:3021 (biomarker_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.28e-04 | 5 | 142 | 2 | C3281201 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 EP400 POTEF TUBA1C SKI HDAC7 SLC9A2 KIAA1217 LPL RPS19BP1 ZNF638 ASXL2 PREX1 LRIF1 AGAP1 | 2.94e-04 | 1105 | 142 | 15 | EFO_0004528 |
| Disease | bipolar disorder, schizophrenia, schizoaffective disorder | 3.41e-04 | 6 | 142 | 2 | EFO_0005411, MONDO_0004985, MONDO_0005090 | |
| Disease | Schizophrenia | DDR1 LAMA2 CHGB GRM8 MET SETDB1 STX1A KAT8 LPL MAD1L1 SMARCA2 CSMD1 TBX1 | 3.54e-04 | 883 | 142 | 13 | C0036341 |
| Disease | Strabismus | 3.64e-04 | 29 | 142 | 3 | HP_0000486 | |
| Disease | Testicular Germ Cell Tumor | 4.33e-04 | 73 | 142 | 4 | EFO_1000566 | |
| Disease | mean reticulocyte volume | ZYG11A EP400 HDAC7 CNOT6 RESF1 APOLD1 MACO1 KIAA1217 LPL ZNF638 TLN2 PREX1 | 5.02e-04 | 799 | 142 | 12 | EFO_0010701 |
| Disease | cognitive function measurement | ATP23 CACNA2D2 TUBA1C OTOL1 GRM8 ERLIN1 ARID1B SLC9A2 KIAA1217 MAD1L1 ZNF638 MYH15 ASXL2 DNAH5 PREX1 STK24 AGAP1 | 5.50e-04 | 1434 | 142 | 17 | EFO_0008354 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0008317, EFO_0008589, EFO_0008596 | |
| Disease | coronary aneurysm | 6.38e-04 | 35 | 142 | 3 | EFO_1000881 | |
| Disease | Lynch Syndrome | 8.10e-04 | 9 | 142 | 2 | C4552100 | |
| Disease | abdominal aortic aneurysm (implicated_via_orthology) | 8.10e-04 | 9 | 142 | 2 | DOID:7693 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor-like protein measurement | 8.14e-04 | 38 | 142 | 3 | EFO_0008154 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.64e-04 | 152 | 142 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 9.70e-04 | 156 | 142 | 5 | DOID:10283 (is_marker_for) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 1.09e-03 | 42 | 142 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.23e-03 | 11 | 142 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Sepsis, mortality | 1.23e-03 | 11 | 142 | 2 | EFO_0004352, HP_0100806 | |
| Disease | neurotic disorder | 1.46e-03 | 101 | 142 | 4 | EFO_0004257 | |
| Disease | gastroesophageal reflux disease | 1.46e-03 | 101 | 142 | 4 | EFO_0003948 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 1.52e-03 | 47 | 142 | 3 | C4551720 | |
| Disease | Autistic Disorder | 1.70e-03 | 261 | 142 | 6 | C0004352 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.73e-03 | 13 | 142 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.73e-03 | 13 | 142 | 2 | C0265338 | |
| Disease | superior frontal gyrus grey matter volume measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0006516 | |
| Disease | triacylglycerol 46:2 measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0010402 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 2.01e-03 | 14 | 142 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | breast cancer (is_marker_for) | 2.06e-03 | 185 | 142 | 5 | DOID:1612 (is_marker_for) | |
| Disease | platelet crit | VMP1 SKI HDAC7 C2CD5 EEF1A1P5 SH3BP4 SLC9A2 CDK13 MAD1L1 FYB1 PREX1 RHOF | 2.24e-03 | 952 | 142 | 12 | EFO_0007985 |
| Disease | low density lipoprotein triglyceride measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0009946 | |
| Disease | Situs ambiguus | 2.32e-03 | 15 | 142 | 2 | C0266642 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.32e-03 | 15 | 142 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Alzheimer disease | 2.48e-03 | 485 | 142 | 8 | MONDO_0004975 | |
| Disease | triglycerides in very large VLDL measurement | 2.51e-03 | 56 | 142 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.51e-03 | 56 | 142 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.51e-03 | 56 | 142 | 3 | EFO_0022251 | |
| Disease | longevity | 2.59e-03 | 284 | 142 | 6 | EFO_0004300 | |
| Disease | fourth ventricle volume measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0010303 | |
| Disease | thyroid volume | 2.64e-03 | 16 | 142 | 2 | EFO_0004865 | |
| Disease | triglycerides in VLDL measurement | 2.91e-03 | 59 | 142 | 3 | EFO_0022326 | |
| Disease | phosphatidylcholine 40:6 measurement | 2.98e-03 | 17 | 142 | 2 | EFO_0010389 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.06e-03 | 60 | 142 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.06e-03 | 60 | 142 | 3 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022274 | |
| Disease | Feeding difficulties | 3.35e-03 | 18 | 142 | 2 | C0232466 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.35e-03 | 18 | 142 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | triglycerides in small HDL measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0022158 | |
| Disease | triglycerides in medium LDL measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.35e-03 | 62 | 142 | 3 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0022299 | |
| Disease | triglycerides in small LDL measurement | 3.83e-03 | 65 | 142 | 3 | EFO_0022323 | |
| Disease | Global developmental delay | 3.97e-03 | 133 | 142 | 4 | C0557874 | |
| Disease | triglycerides in very small VLDL measurement | 4.35e-03 | 68 | 142 | 3 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 4.35e-03 | 68 | 142 | 3 | EFO_0022327 | |
| Disease | aspartate aminotransferase measurement | CACNA2D2 PPP1R3B ERLIN1 SETDB1 SUGP1 ZNF638 NLRC5 CSMD1 GOT2 ATG16L2 AGAP1 | 4.42e-03 | 904 | 142 | 11 | EFO_0004736 |
| Disease | interleukin-2 receptor subunit alpha measurement | 4.55e-03 | 21 | 142 | 2 | EFO_0010587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFQDVAQKVVALRKK | 241 | Q96P47 | |
| RIAKEKKALADQQKA | 2521 | Q96L91 | |
| KKQEKANRIVAEAIA | 456 | Q9HCK8 | |
| RIQKTKADINATKVK | 446 | Q86X02 | |
| QAKRAELEKLKSQVT | 1576 | Q7Z7A1 | |
| QFLTERKKAEKQVAS | 2061 | Q7Z7A1 | |
| AKQARVSQELKKAAK | 216 | Q8NAA4 | |
| VFQDVAQKIVATRKK | 221 | Q9UPQ3 | |
| LRAVLKANKQTAEVA | 691 | Q96G01 | |
| NAQFQVKKAIELKSR | 306 | Q96PZ7 | |
| QAKVTSRKIKNEAAS | 961 | Q96M83 | |
| VQANVRNKKVFKEAV | 346 | Q9NY47 | |
| NGKARKEAVQTAAKE | 16 | Q9ULA0 | |
| EQARVAKEAKKQQAI | 911 | Q9UIF8 | |
| AKKESVKLLQVIANS | 121 | Q6PIY5 | |
| ATKNARNDFLKEVKI | 661 | Q08345 | |
| KLKAQRTQARAASQK | 306 | Q8IXS2 | |
| EKIAQVAKIRFQQKV | 221 | O75477 | |
| IVKKNNLFVVDRSDK | 1861 | Q8NFD5 | |
| DVAQALKRKQKSVSI | 3481 | Q96M86 | |
| VKRIFSKAIVDNKNL | 386 | Q96QD5 | |
| AQKEVFRTKTAALKQ | 51 | A6NFT4 | |
| AKNVNKTAEKVRIIK | 421 | Q49A88 | |
| KKAAQEQVLNASRAK | 606 | Q99543 | |
| AELNKNKKARAAEAA | 451 | Q14004 | |
| NKVKANLNAVSKAEA | 766 | Q5H9R4 | |
| AIQAQKLRNSAKGKV | 41 | Q86WX3 | |
| KAKAQLVKAQRAAAA | 661 | Q76L83 | |
| VQGKRKAASKAAAQQ | 166 | Q96B01 | |
| KEIFAKVSKQRQNSI | 171 | P57735 | |
| KLNKAEIEQSQRVVK | 181 | P51157 | |
| RNKQVKQAFSDSIKR | 291 | Q9NZP2 | |
| ATVNVKQAAKVVKAS | 556 | Q9H0B3 | |
| VSQAVLKAKIQKLAE | 221 | Q96LR9 | |
| LAVRNISKEVAKKAV | 191 | Q9Y6H3 | |
| SKQKIIDAQEKRIAS | 1126 | Q5VWQ8 | |
| KALEKNTNVEARTKV | 121 | Q14517 | |
| VLDNKKRTALIKAVQ | 201 | A5A3E0 | |
| NKDVKAAVRDLIFQK | 301 | P0DN81 | |
| AELKNQRLKEVFQTK | 611 | Q9Y6D9 | |
| FAQRAKLIKNKAVVN | 356 | Q9NS87 | |
| NNVASKILKTFVDRK | 311 | Q5T3J3 | |
| FEEIKKANQAAARKL | 86 | Q6ZNB6 | |
| VERKNSARKASIVKN | 56 | P16333 | |
| NARRKLKAAVKAVVA | 321 | Q16566 | |
| KNRLALTKTVKDAVQ | 106 | Q9H7Z6 | |
| KKLKADLQASRQVEQ | 391 | Q8N5G2 | |
| FAIQKIRVKAGETQK | 426 | P06858 | |
| LQSKAVKRKTTAENV | 406 | Q9UHC1 | |
| LQEARNAEEKAKKAI | 1751 | Q9UKX2 | |
| KVAKTRKENVAKSLA | 1241 | Q6ZU69 | |
| RKIDAAKNTFQSKIN | 286 | O15117 | |
| VVKKVQAAQSEAKVV | 341 | Q16891 | |
| FAQIEVNEKKIRQKA | 826 | Q9UL01 | |
| AIKAKQAEAISKRQE | 301 | Q13601 | |
| FRNIITNKELKEKNA | 171 | A0A1B0GV03 | |
| AAKLQAVKDKARQAN | 2031 | P24043 | |
| KKSNQAFAVKIISKR | 446 | O75582 | |
| FNKSQAIESVERKKQ | 221 | Q9H4K1 | |
| EQNVQKRKRSFKAVV | 846 | O00222 | |
| KQAAVVQVLKKLATR | 591 | Q86WI3 | |
| AARIKINEEFKNNKS | 31 | Q5U5X0 | |
| RKNDGSAVSKKENIV | 1021 | Q7Z6E9 | |
| RRKDAQDQAKVKVTV | 1366 | Q7Z442 | |
| VLDNKKRTALIKAVQ | 201 | A0JP26 | |
| ENKVNSEKVKLSLRN | 46 | Q4JDL3 | |
| VLDNKKRTALIKAVQ | 201 | Q6S8J3 | |
| QLKVQKDARNVSLSK | 301 | Q92772 | |
| KEAVKKKAAEQTAAR | 736 | Q01780 | |
| KKAAEQTAAREQAKE | 741 | Q01780 | |
| KAARAQAKVARTQAK | 291 | Q8IV32 | |
| QAKVARTQAKAAKAR | 296 | Q8IV32 | |
| AAKARAKAKAAQVKA | 306 | Q8IV32 | |
| LAKSITQEKNRVKEA | 726 | B1AJZ9 | |
| QQASIISRKKEAKAE | 346 | Q8WYA0 | |
| KFSEKIALQKQRQAE | 21 | Q53ET0 | |
| KKNIVVASNKVSSRV | 166 | O60336 | |
| KVKNVSVKDVRRGNV | 311 | Q5VTE0 | |
| KAQEAKSIIRNLDKQ | 1421 | A4D0S4 | |
| IDNVKKARVQVVAGK | 301 | P01042 | |
| AVQVKSIQDAIRDKK | 1936 | Q9NYC9 | |
| KRSAVASSVVKQKLA | 76 | Q8WUI4 | |
| IKEAQKTAAVALAKA | 371 | Q5W0V3 | |
| AAKSAAKVAAKAQLR | 556 | P15502 | |
| AEFKREVQLQAIVKK | 601 | Q9BY12 | |
| NAFLNERKQASAIKK | 196 | P05060 | |
| LKKKAQAEANATAIS | 521 | Q86YS7 | |
| SEVKNIIDKASRNLK | 381 | Q9ULM6 | |
| KAEVQKVKDRAQAIV | 3256 | Q8TE73 | |
| ARISLVAQNKKQFKS | 401 | A6NHN0 | |
| KDKAIAGTVKVQNLA | 141 | Q86XI6 | |
| SASKLSRQKNKNVEI | 341 | Q3ZCT8 | |
| VLDNKKRTALIKAVQ | 201 | B2RU33 | |
| KRSTKKEVFNILQAA | 306 | P08581 | |
| ALKAAAAAQKQAKRR | 226 | P82914 | |
| REAAKVALSALKKAQ | 186 | Q9HBH0 | |
| TNIIAAKAAEVRANK | 16 | Q9UI12 | |
| SRCVQKALKKADKQV | 671 | Q969S9 | |
| EKQRTAAIAEVAKSK | 131 | Q9H7E2 | |
| QSVFKSARQKIAKEE | 1496 | P51531 | |
| KAAAKSAALQVTKQI | 246 | Q92733 | |
| KASEQAKVVRGFQLK | 551 | Q9P0V3 | |
| RNKVVKVTAPEAQAK | 296 | Q9UI40 | |
| FKGIDNRTQKVVAIK | 51 | Q9Y6E0 | |
| ARKTQKTVLKDANQT | 591 | Q9HCM1 | |
| KKAVANAVRQEVKSL | 56 | Q1AE95 | |
| RAEVAESQVNKLKIK | 1921 | Q9Y2K3 | |
| EKNKAVVVKSVQRGS | 641 | Q8TCU6 | |
| KRAKVSQALFAKVAA | 496 | Q9UPW6 | |
| VSAKNRAVSIEKAEK | 956 | Q5T5P2 | |
| ARVFQKAVDQSIEKK | 26 | Q14108 | |
| KRKILENAASAQKAT | 236 | Q9Y5N6 | |
| VLDNKKRTALTKAVQ | 201 | P0CG38 | |
| RAKQAIQEELNKVKA | 891 | Q5VT25 | |
| AKQSKLANIDFRQKE | 306 | Q8N1H7 | |
| VKQEEKLSAALQAKR | 571 | P12755 | |
| TTEIKKRANNVRNKL | 81 | Q13277 | |
| LESQLAQSRKQVAKK | 476 | Q15047 | |
| RKAEAQIAAKNLDKE | 81 | P00505 | |
| SSVAVIEAKKKNNVA | 331 | O15204 | |
| DIVFSKVKAKNARTI | 51 | P59282 | |
| IRKEAQKSQAASQKV | 241 | Q8IWZ8 | |
| DLLAVVAASQKKQAI | 86 | P01135 | |
| KDVNAAIATIKTKRT | 326 | P0DPH8 | |
| KKAVANAVQQEVKSL | 56 | Q8IXX5 | |
| LDVKRSNKKQQAVSE | 486 | Q9UBY0 | |
| SAQEFQKQLTKAKRI | 136 | Q8WU10 | |
| IQQATTVKNKDIRKF | 161 | P32969 | |
| SGFVAIKKKQQDVVR | 11 | Q9UJC5 | |
| IKKKQQDVVRFLEAN | 16 | Q9UJC5 | |
| ANKVRSKLKSIEQSI | 86 | Q16623 | |
| CVVKTQRKAKQAETL | 511 | Q9NW82 | |
| QVKKAALTQAKSQRT | 31 | Q96I25 | |
| QVKIRAKKDNVAGVT | 91 | Q9Y5K8 | |
| KDVNAAIATIKTKRT | 326 | P0DPH7 | |
| ALDKARAKNKDVLQA | 326 | Q9UNH7 | |
| EKANAAAAALDKKQR | 596 | Q9H6N6 | |
| SASQVDVAVKINKKV | 601 | P54278 | |
| RVATNAAAQNAIKKK | 901 | Q9Y4G6 | |
| AAAQNAIKKKIVNRL | 906 | Q9Y4G6 | |
| ALKTKQAIRNVIAKA | 801 | Q5TAH2 | |
| KSQEAQVLKQLAEKR | 96 | Q93045 | |
| KDVNAAIATIKTKRT | 326 | Q71U36 | |
| LTAQFVQKTKLDRKN | 406 | Q5VWN6 | |
| KDVNAAIATIKTKRT | 326 | Q6PEY2 | |
| VKKNAKVAGVSVQLE | 101 | O43435 | |
| QKSNLFRQKAVTAEK | 226 | Q86UQ0 | |
| KDVNAAIATIKTKRS | 326 | P68363 | |
| KEQVSIKAAIKAANR | 456 | Q9NUQ3 | |
| NQTLKARNDKSVKEI | 31 | Q5TAX3 | |
| VNIQKAKISTAAFIK | 106 | Q6WRX3 | |
| KDVNAAIATIKTKRT | 326 | Q9BQE3 | |
| ECKQVSDKAVSLQRK | 651 | Q14966 | |
| QKDALRTVLKQKAQS | 111 | Q9BVV6 | |
| KDVNAAIAAIKTKRS | 326 | P68366 | |
| KKDQRIAVTLNKTAK | 76 | A0A0B4J241 | |
| ASRAKLAVQKLVQKV | 241 | Q96GC9 | |
| KKSANIEAVDVAKRL | 871 | P23378 | |
| KEKSQKASERLLVQN | 506 | A6PVS8 |